Skip to Content

93 154 (Ticlopidine 250 mg)

Pill imprint 93 154 has been identified as Ticlopidine hydrochloride 250 mg.

Ticlopidine is used in the treatment of cerebral thrombosis/embolism and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Ticlopidine 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ticlopidine hydrochloride 250 mg 93 154 Front
Ticlopidine hydrochloride 250 mg 93 154 Back
Ticlopidine hydrochloride 250 mg 93 154
Ticlopidine hydrochloride 250 mg 93 154
Ticlopidine hydrochloride
Imprint:
93 154
Strength:
250 mg
Color:
White
Size:
15.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Platelet aggregation inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-0154
Inactive Ingredients:
butylated hydroxyanisole
corn starch
hypromelloses
magnesium stearate
microcrystalline cellulose
polyethylene glycol
povidone
stearic acid
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
42291-0803 AvKare, Inc.

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide